CORT
Corcept Therapeutics Incorporated
Stock
$116.23+2.20 (+1.93%)Close Oct 2, 2026
- Operating income, 2025
- $45M
- YoY, 2025
- −67.3%
- 5-year CAGR
- −19.0%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $45M | −67.3% |
| 2024 | $137M | +27.7% |
| 2023 | $107M | −4.8% |
| 2022 | $113M | −9.5% |
| 2021 | $124M | −2.9% |
| 2020 | $128M | +14.9% |
| 2019 | $112M | +24.7% |
| 2018 | $89M | +69.3% |
| 2017 | $53M | +419.3% |
| 2016 | $10M | — |
| 2015 | −$3.4M | — |
| 2014 | −$28M | — |
| 2013 | −$41M | — |
| 2012 | −$36M | — |
| 2011 | −$32M | — |
| 2010 | −$27M | — |
| 2009 | −$20M | — |